Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Cytopathologic interpretation of ascites due to malignancy.

Kalogeraki A, Karvela-Kalogeraki I, Tamiolakis D, Petraki P, Papathanasiou A, Saridaki Z, Stathopoulos EN, Tzardi M.

J BUON. 2012 Jul-Sep;17(3):446-51. Review.

PMID:
23033279
2.

Pancreatic cancer. Cytologic study of peritoneal washings.

Lei S, Kini J, Kim K, Howard JM.

Arch Surg. 1994 Jun;129(6):639-42.

PMID:
8204039
3.
4.

Malignant ascites. Clinical and experimental observations.

Garrison RN, Kaelin LD, Galloway RH, Heuser LS.

Ann Surg. 1986 Jun;203(6):644-51.

5.

Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.

Chen SJ, Wang SS, Lu CW, Chao Y, Lee FY, Lee SD, Wu SL, Cherng KL, Lo KJ.

J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):396-400.

PMID:
7948823
6.

Metastatic peritoneal mesothelioma in the setting of recurrent ascites: a case report.

Samedi V, White S, Zimarowski MJ, Harris A, Saffitz J, Wang HH.

Diagn Cytopathol. 2010 Sep;38(9):675-81. doi: 10.1002/dc.21300.

PMID:
20049974
7.

Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.

van de Molengraft FJ, van 't Hof MA, Herman CJ, Vooijs PG.

Anal Quant Cytol. 1982 Sep;4(3):217-20.

PMID:
7149486
8.

[Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].

Rieder H, Ramadori G, Meyer zum Büschenfelde KH.

Z Gastroenterol. 1991 Jan;29(1):16-21. German.

PMID:
2058224
9.

Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.

Castaldo G, Oriani G, Cimino L, Topa M, Mostarda I, Castellano L, Del Vecchio-Blanco C, Budillon G, Salvatore F, Sacchetti L.

Clin Chem. 1994 Mar;40(3):478-83.

10.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.

Oncol Rep. 2003 Jan-Feb;10(1):89-95.

PMID:
12469150
11.

Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".

Runyon BA.

J Clin Gastroenterol. 1994 Mar;18(2):94-8. Review.

PMID:
8189030
12.

Ascitic fluid analysis in malignancy-related ascites.

Runyon BA, Hoefs JC, Morgan TR.

Hepatology. 1988 Sep-Oct;8(5):1104-9.

PMID:
3417231
13.

Peritoneal lymphomatosis with ascites. A characterization.

Runyon BA, Hoefs JC.

Arch Intern Med. 1986 May;146(5):887-8.

PMID:
3963980
14.

[Clinical evaluation of polyamine assay in diagnosis of malignant ascites].

Peng A, Zhao S, Zhang X, Zhang G.

Hunan Yi Ke Da Xue Xue Bao. 1997;22(1):59-62, 65. Chinese.

PMID:
9868032
15.

Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.

Rana SV, Babu SG, Kocchar R.

Med Sci Monit. 2005 Mar;11(3):CR136-42.

PMID:
15735567
18.

[Recent aspects in the diagnosis and therapy of ascites].

Gerbes AL.

Z Gastroenterol. 1987 Oct;25(10):677-82. Review. German.

PMID:
3318185
19.

Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.

Gopaldas R, Kunasani R, Plymyer MR, Bloch RS.

Surg Oncol. 2005 Jul;14(1):11-25. Epub 2004 Dec 9. Review.

PMID:
15777886
20.

Carcinoembryonic antigen gradients between plasma and malignant ascites: use in detecting peritoneal and liver metastases.

Loewenstein MS, Rittgers RA, Kupchik HZ, Zamcheck N.

J Natl Cancer Inst. 1981 May;66(5):803-6.

PMID:
6939926

Supplemental Content

Support Center